Equity Research, Broker Reports, and media content on Verona Pharma

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Verona Pharma
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Verona Pharma. We currently have 109 research reports from 6 professional analysts.

Open
37.5p
Range Today
37.5/37.5p
52 Week
31.5/75.0p
Daily Volume
0.0k
# Shares
106.2m
Daily Liquidity
(0%)
Pension Liability
£0m
Enterprise Value
£36.0m
Market Cap
£39.8m
Latest PE (hist)
Div Yield
Date Source Announcement
31Mar20 07:00 GNW Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD
20Mar20 11:28 GNW Verona Pharma plc: Issue of Equity and Total Voting Rights
17Mar20 14:06 RNS Second Price Monitoring Extn
17Mar20 14:01 RNS Price Monitoring Extension
16Mar20 17:13 GNW 2019 Annual Report and Accounts and Notice of AGM
05Mar20 16:01 GNW Grant of Restricted Stock Units and PDMR Dealings
27Feb20 07:00 GNW Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update
  • Frequency of research reports

     

  • Research reports on

    Verona Pharma

  • Providers covering

    Verona Pharma